Overview

Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission

Status:
Unknown status
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Telbivudine in pregnancy for the prevention of HBV perinatal transmission in highly viraemic mothers.
Phase:
Phase 4
Details
Lead Sponsor:
Southeast University, China
Treatments:
Telbivudine
Vaccines